Table 2

Patient demographics and disease characteristics

Subjects (n)24
Age (yr)
 Median59.5
 Range41–75
Sex
 Men16 (67%)
 Women8 (33%)
Karnofsky performance status:
 Missing1 (4%)
 70–856 (25%)
 90–10017 (71%)
Histology
 NSCLCa14 (58%)
 Salivary6 (25%)
 HNSCC4 (17%)
Prior chemotherapy (n = 21)13
Prior taxane (n = 21)9
  • a NSCLC, non-small cell lung cancer; HNSCC, head and neck squamous cell carcinoma.